Insider filing · GKOS
Thomas William Burns
CHAIRMAN & CEO
profile →
Glaukos Corporation
GKOS · Healthcare · 31 filings in 24 months
ticker →
Thomas William Burns sold $31.6M of Glaukos (GKOS)
Executed Jan 8, disclosed Jan 20, 12 days later, against a two-business-day limit.
Value, as filed
$31.6M
275,000 sh across 2 lots
Executed
Jan 8
the trade date, as filed
Disclosed
Jan 20
12 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TBThomas William Burns (CHAIRMAN & CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Glaukos Corporation (GKOS). The largest single filing was $31.6M of GKOS (275,000 sh across 2 lots, as filed), executed Jan 8.
The name
GKOSHealthcare · Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→